 | • レポートコード：MRC2312MG08443 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、69ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の小型干渉RNA（siRNA）市場規模と予測を収録しています。・世界の小型干渉RNA（siRNA）市場：売上、2018年-2023年、2024年-2029年 ・世界の小型干渉RNA（siRNA）市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の小型干渉RNA（siRNA）市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「siRNA一般化学合成」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 小型干渉RNA（siRNA）のグローバル主要企業は、Agilent Technologies、 Merck KGaA、 QIAGEN (Exiqon)、 NanoString Technologies, Inc.、 Dharmacon (Horizon Discovery Group)、 Synlogic、 GeneCopoeia, Inc.、 New England Biolabs、 Quantabio、 NanoString Technologies, Inc.、 BioGenex、 SeqMatic LLCなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、小型干渉RNA（siRNA）のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の小型干渉RNA（siRNA）市場：タイプ別、2018年-2023年、2024年-2029年 世界の小型干渉RNA（siRNA）市場：タイプ別市場シェア、2022年 ・siRNA一般化学合成、ステロール修飾siRNA化学合成 世界の小型干渉RNA（siRNA）市場：用途別、2018年-2023年、2024年-2029年 世界の小型干渉RNA（siRNA）市場：用途別市場シェア、2022年 ・がん、感染症、免疫疾患、循環器疾患、神経疾患、その他 世界の小型干渉RNA（siRNA）市場：地域・国別、2018年-2023年、2024年-2029年 世界の小型干渉RNA（siRNA）市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における小型干渉RNA（siRNA）のグローバル売上、2018年-2023年 ・主要企業における小型干渉RNA（siRNA）のグローバル売上シェア、2022年 ・主要企業における小型干渉RNA（siRNA）のグローバル販売量、2018年-2023年 ・主要企業における小型干渉RNA（siRNA）のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Agilent Technologies、 Merck KGaA、 QIAGEN (Exiqon)、 NanoString Technologies, Inc.、 Dharmacon (Horizon Discovery Group)、 Synlogic、 GeneCopoeia, Inc.、 New England Biolabs、 Quantabio、 NanoString Technologies, Inc.、 BioGenex、 SeqMatic LLC ************************************************************* ・調査・分析レポートの概要 小型干渉RNA（siRNA）市場の定義 市場セグメント 世界の小型干渉RNA（siRNA）市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の小型干渉RNA（siRNA）市場規模 世界の小型干渉RNA（siRNA）市場規模：2022年 VS 2029年 世界の小型干渉RNA（siRNA）市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの小型干渉RNA（siRNA）の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の小型干渉RNA（siRNA）製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：siRNA一般化学合成、ステロール修飾siRNA化学合成 小型干渉RNA（siRNA）のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：がん、感染症、免疫疾患、循環器疾患、神経疾患、その他 小型干渉RNA（siRNA）の用途別グローバル売上・予測 ・地域別市場分析 地域別小型干渉RNA（siRNA）市場規模 2022年と2029年 地域別小型干渉RNA（siRNA）売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Agilent Technologies、 Merck KGaA、 QIAGEN (Exiqon)、 NanoString Technologies, Inc.、 Dharmacon (Horizon Discovery Group)、 Synlogic、 GeneCopoeia, Inc.、 New England Biolabs、 Quantabio、 NanoString Technologies, Inc.、 BioGenex、 SeqMatic LLC ... |
This research report provides a comprehensive analysis of the Small Interfering RNA (siRNA) market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Small Interfering RNA (siRNA) market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Small Interfering RNA (siRNA), challenges faced by the industry, and potential opportunities for market players.
The global Small Interfering RNA (siRNA) market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Small Interfering RNA (siRNA) market presents opportunities for various stakeholders, including Cancer, Infectious Diseases. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Small Interfering RNA (siRNA) market. Additionally, the growing consumer demand present avenues for market expansion.
The global Small Interfering RNA (siRNA) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Small Interfering RNA (siRNA) market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Small Interfering RNA (siRNA) market.
Market Overview: The report provides a comprehensive overview of the Small Interfering RNA (siRNA) market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., General Chemical Synthesis of siRNA, Sterol Modified Chemical Synthesis of siRNA), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Small Interfering RNA (siRNA) market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Small Interfering RNA (siRNA) market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Small Interfering RNA (siRNA) market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Small Interfering RNA (siRNA) market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Small Interfering RNA (siRNA) market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Small Interfering RNA (siRNA) market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Small Interfering RNA (siRNA), including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Small Interfering RNA (siRNA) market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Small Interfering RNA (siRNA) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
General Chemical Synthesis of siRNA
Sterol Modified Chemical Synthesis of siRNA
Market segment by Application
Cancer
Infectious Diseases
Immunological Disorder
Cardiovascular Disease
Neurological Disease
Others
Global Small Interfering RNA (siRNA) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Agilent Technologies
Merck KGaA
QIAGEN (Exiqon)
NanoString Technologies, Inc.
Dharmacon (Horizon Discovery Group)
Synlogic
GeneCopoeia, Inc.
New England Biolabs
Quantabio
NanoString Technologies, Inc.
BioGenex
SeqMatic LLC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Small Interfering RNA (siRNA), market overview.
Chapter 2: Global Small Interfering RNA (siRNA) market size in revenue.
Chapter 3: Detailed analysis of Small Interfering RNA (siRNA) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Small Interfering RNA (siRNA) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Small Interfering RNA (siRNA) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Small Interfering RNA (siRNA) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Small Interfering RNA (siRNA) Overall Market Size
2.1 Global Small Interfering RNA (siRNA) Market Size: 2022 VS 2029
2.2 Global Small Interfering RNA (siRNA) Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Small Interfering RNA (siRNA) Players in Global Market
3.2 Top Global Small Interfering RNA (siRNA) Companies Ranked by Revenue
3.3 Global Small Interfering RNA (siRNA) Revenue by Companies
3.4 Top 3 and Top 5 Small Interfering RNA (siRNA) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Small Interfering RNA (siRNA) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Small Interfering RNA (siRNA) Players in Global Market
3.6.1 List of Global Tier 1 Small Interfering RNA (siRNA) Companies
3.6.2 List of Global Tier 2 and Tier 3 Small Interfering RNA (siRNA) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Small Interfering RNA (siRNA) Market Size Markets, 2022 & 2029
4.1.2 General Chemical Synthesis of siRNA
4.1.3 Sterol Modified Chemical Synthesis of siRNA
4.2 By Type – Global Small Interfering RNA (siRNA) Revenue & Forecasts
4.2.1 By Type – Global Small Interfering RNA (siRNA) Revenue, 2018-2023
4.2.2 By Type – Global Small Interfering RNA (siRNA) Revenue, 2024-2029
4.2.3 By Type – Global Small Interfering RNA (siRNA) Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Small Interfering RNA (siRNA) Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Infectious Diseases
5.1.4 Immunological Disorder
5.1.5 Cardiovascular Disease
5.1.6 Neurological Disease
5.1.7 Others
5.2 By Application – Global Small Interfering RNA (siRNA) Revenue & Forecasts
5.2.1 By Application – Global Small Interfering RNA (siRNA) Revenue, 2018-2023
5.2.2 By Application – Global Small Interfering RNA (siRNA) Revenue, 2024-2029
5.2.3 By Application – Global Small Interfering RNA (siRNA) Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Small Interfering RNA (siRNA) Market Size, 2022 & 2029
6.2 By Region – Global Small Interfering RNA (siRNA) Revenue & Forecasts
6.2.1 By Region – Global Small Interfering RNA (siRNA) Revenue, 2018-2023
6.2.2 By Region – Global Small Interfering RNA (siRNA) Revenue, 2024-2029
6.2.3 By Region – Global Small Interfering RNA (siRNA) Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Small Interfering RNA (siRNA) Revenue, 2018-2029
6.3.2 US Small Interfering RNA (siRNA) Market Size, 2018-2029
6.3.3 Canada Small Interfering RNA (siRNA) Market Size, 2018-2029
6.3.4 Mexico Small Interfering RNA (siRNA) Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Small Interfering RNA (siRNA) Revenue, 2018-2029
6.4.2 Germany Small Interfering RNA (siRNA) Market Size, 2018-2029
6.4.3 France Small Interfering RNA (siRNA) Market Size, 2018-2029
6.4.4 U.K. Small Interfering RNA (siRNA) Market Size, 2018-2029
6.4.5 Italy Small Interfering RNA (siRNA) Market Size, 2018-2029
6.4.6 Russia Small Interfering RNA (siRNA) Market Size, 2018-2029
6.4.7 Nordic Countries Small Interfering RNA (siRNA) Market Size, 2018-2029
6.4.8 Benelux Small Interfering RNA (siRNA) Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Small Interfering RNA (siRNA) Revenue, 2018-2029
6.5.2 China Small Interfering RNA (siRNA) Market Size, 2018-2029
6.5.3 Japan Small Interfering RNA (siRNA) Market Size, 2018-2029
6.5.4 South Korea Small Interfering RNA (siRNA) Market Size, 2018-2029
6.5.5 Southeast Asia Small Interfering RNA (siRNA) Market Size, 2018-2029
6.5.6 India Small Interfering RNA (siRNA) Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Small Interfering RNA (siRNA) Revenue, 2018-2029
6.6.2 Brazil Small Interfering RNA (siRNA) Market Size, 2018-2029
6.6.3 Argentina Small Interfering RNA (siRNA) Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Small Interfering RNA (siRNA) Revenue, 2018-2029
6.7.2 Turkey Small Interfering RNA (siRNA) Market Size, 2018-2029
6.7.3 Israel Small Interfering RNA (siRNA) Market Size, 2018-2029
6.7.4 Saudi Arabia Small Interfering RNA (siRNA) Market Size, 2018-2029
6.7.5 UAE Small Interfering RNA (siRNA) Market Size, 2018-2029
7 Small Interfering RNA (siRNA) Companies Profiles
7.1 Agilent Technologies
7.1.1 Agilent Technologies Company Summary
7.1.2 Agilent Technologies Business Overview
7.1.3 Agilent Technologies Small Interfering RNA (siRNA) Major Product Offerings
7.1.4 Agilent Technologies Small Interfering RNA (siRNA) Revenue in Global Market (2018-2023)
7.1.5 Agilent Technologies Key News & Latest Developments
7.2 Merck KGaA
7.2.1 Merck KGaA Company Summary
7.2.2 Merck KGaA Business Overview
7.2.3 Merck KGaA Small Interfering RNA (siRNA) Major Product Offerings
7.2.4 Merck KGaA Small Interfering RNA (siRNA) Revenue in Global Market (2018-2023)
7.2.5 Merck KGaA Key News & Latest Developments
7.3 QIAGEN (Exiqon)
7.3.1 QIAGEN (Exiqon) Company Summary
7.3.2 QIAGEN (Exiqon) Business Overview
7.3.3 QIAGEN (Exiqon) Small Interfering RNA (siRNA) Major Product Offerings
7.3.4 QIAGEN (Exiqon) Small Interfering RNA (siRNA) Revenue in Global Market (2018-2023)
7.3.5 QIAGEN (Exiqon) Key News & Latest Developments
7.4 NanoString Technologies, Inc.
7.4.1 NanoString Technologies, Inc. Company Summary
7.4.2 NanoString Technologies, Inc. Business Overview
7.4.3 NanoString Technologies, Inc. Small Interfering RNA (siRNA) Major Product Offerings
7.4.4 NanoString Technologies, Inc. Small Interfering RNA (siRNA) Revenue in Global Market (2018-2023)
7.4.5 NanoString Technologies, Inc. Key News & Latest Developments
7.5 Dharmacon (Horizon Discovery Group)
7.5.1 Dharmacon (Horizon Discovery Group) Company Summary
7.5.2 Dharmacon (Horizon Discovery Group) Business Overview
7.5.3 Dharmacon (Horizon Discovery Group) Small Interfering RNA (siRNA) Major Product Offerings
7.5.4 Dharmacon (Horizon Discovery Group) Small Interfering RNA (siRNA) Revenue in Global Market (2018-2023)
7.5.5 Dharmacon (Horizon Discovery Group) Key News & Latest Developments
7.6 Synlogic
7.6.1 Synlogic Company Summary
7.6.2 Synlogic Business Overview
7.6.3 Synlogic Small Interfering RNA (siRNA) Major Product Offerings
7.6.4 Synlogic Small Interfering RNA (siRNA) Revenue in Global Market (2018-2023)
7.6.5 Synlogic Key News & Latest Developments
7.7 GeneCopoeia, Inc.
7.7.1 GeneCopoeia, Inc. Company Summary
7.7.2 GeneCopoeia, Inc. Business Overview
7.7.3 GeneCopoeia, Inc. Small Interfering RNA (siRNA) Major Product Offerings
7.7.4 GeneCopoeia, Inc. Small Interfering RNA (siRNA) Revenue in Global Market (2018-2023)
7.7.5 GeneCopoeia, Inc. Key News & Latest Developments
7.8 New England Biolabs
7.8.1 New England Biolabs Company Summary
7.8.2 New England Biolabs Business Overview
7.8.3 New England Biolabs Small Interfering RNA (siRNA) Major Product Offerings
7.8.4 New England Biolabs Small Interfering RNA (siRNA) Revenue in Global Market (2018-2023)
7.8.5 New England Biolabs Key News & Latest Developments
7.9 Quantabio
7.9.1 Quantabio Company Summary
7.9.2 Quantabio Business Overview
7.9.3 Quantabio Small Interfering RNA (siRNA) Major Product Offerings
7.9.4 Quantabio Small Interfering RNA (siRNA) Revenue in Global Market (2018-2023)
7.9.5 Quantabio Key News & Latest Developments
7.10 NanoString Technologies, Inc.
7.10.1 NanoString Technologies, Inc. Company Summary
7.10.2 NanoString Technologies, Inc. Business Overview
7.10.3 NanoString Technologies, Inc. Small Interfering RNA (siRNA) Major Product Offerings
7.10.4 NanoString Technologies, Inc. Small Interfering RNA (siRNA) Revenue in Global Market (2018-2023)
7.10.5 NanoString Technologies, Inc. Key News & Latest Developments
7.11 BioGenex
7.11.1 BioGenex Company Summary
7.11.2 BioGenex Business Overview
7.11.3 BioGenex Small Interfering RNA (siRNA) Major Product Offerings
7.11.4 BioGenex Small Interfering RNA (siRNA) Revenue in Global Market (2018-2023)
7.11.5 BioGenex Key News & Latest Developments
7.12 SeqMatic LLC
7.12.1 SeqMatic LLC Company Summary
7.12.2 SeqMatic LLC Business Overview
7.12.3 SeqMatic LLC Small Interfering RNA (siRNA) Major Product Offerings
7.12.4 SeqMatic LLC Small Interfering RNA (siRNA) Revenue in Global Market (2018-2023)
7.12.5 SeqMatic LLC Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer